Danakali has received a twelve month price target of $0.64 from broker Hartleys. The broker added that its spot price valuation is even higher at $1.31.
All S&P 500 sectors advanced overnight. By the close the Dow Jones had rallied 168 points to 17,888.
The ASX SPI 200 is off two points to 5262.
As news from the Reserve Bank of Australia helped the Australian All Ordinaries mark gains, this uranium developer paved its way to being the yellowcake sector’s next global producer.
Aspire Mining has received an important railway construction licence in Mongolia, which helps pave the way for coal deliveries from its Ovoot project to two of the largest, most energy-hungry countries in the world.
Peninsula Energy has been cleared to begin in-situ recovery of uranium at its Lance project in the U.S., setting up the developer’s transition to producer status ahead of a listing on a U.S. stock exchange, a nuclear market rebound and a potential project expansion.
Andrew Haythorpe, director, VTX Holdings, has joined Proactive Q&A Sessions™ exclusively to discuss the acquisition of NexGen Networks, and the transition to Wangle Technologies.
Cellmid has set up a springboard for the commercial development of a novel autoimmune disease treatment method with the grant of a new European patent.
Cardinal Resources has received a Speculative Buy and a 12 month price target of $0.27 from Hartleys, which is almost double the last traded price.
Grades of over one ounce per tonne have now been found over the entire 900 metres of the upper gold zone which is still open at depth and along strike.
Buru Energy has spudded a low-risk and highly prospective conventional oil well near its producing Ungani oil property in Western Australia’s onshore Canning Superbasin.
Anteo Diagnostics has outlined a funding package including a A$12 million entitlement offer to finalise an acquisition expected to transition the company into a cashflow positive business model.
Where this latest resource at the D Zone neatly fits into place for Avalon, is that it underpins the Viscaria copper-only Scoping Study due to be released in December.